CNBX CNBX Pharmaceuticals Inc.
Pharmaceutical Preparations · OTC · SEC CIK 1343009 · Fiscal year ends 08/31
Financial factors as of 2026-02-28 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-24.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,121.6%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets17,104.8%
Debt / equity—
Current ratio0.01x
Interest coverage-6.65x
Cash quality & payout
Operating cash flow / net income0.43x
Accruals ratio-638.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-08-31 | FY20242024-08-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $130,074 |
| R&D expense | $0 | $194,788 |
| SG&A expense | $271,691 | $518,426 |
| Operating income | -$271,691 | -$583,139 |
| Interest expense | $39,819 | — |
| Net income | -$313,976 | -$695,198 |
| EBITDA | -$271,691 | -$510,819 |
| EPS (basic) | 0.00 | -0.02 |
| EPS (diluted) | 0.00 | -0.02 |
| Weighted avg. shares (diluted) | 90.65M | 30.25M |
| Banking | ||
| Net interest income | -$39,813 | -$16,798 |
| Balance sheet | ||
| Cash & equivalents | $15,111 | $26,416 |
| Current assets | $18,437 | $31,383 |
| PP&E, net | $0 | $0 |
| Total assets | $18,437 | $31,383 |
| Current liabilities | $2.51M | $2.51M |
| Short-term debt | $0 | — |
| Total liabilities | $2.51M | $2.51M |
| Shareholders' equity | -$2.50M | -$2.48M |
| Shares outstanding | 553.96M | 31.11M |
| Cash flow statement | ||
| Operating cash flow | -$171,305 | -$244,269 |
| Investing cash flow | $0 | $113,477 |
| Financing cash flow | $160,000 | $27,512 |
| Depreciation & amortization | $0 | $72,320 |
| Stock-based compensation | $0 | $139,720 |
Free plan shows the latest 2 periods; Pro shows all 21 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.